
July to September 2021
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| AFLIBERCEPT | $122,117,625 | 102,473 |
| PEMBROLIZUMAB | $111,048,928 | 13,098 |
| NIVOLUMAB | $105,142,519 | 13,631 |
| USTEKINUMAB | $72,069,057 | 10,107 |
| APIXABAN | $69,426,799 | 839,877 |
| ADALIMUMAB | $66,737,762 | 74,294 |
| LENALIDOMIDE | $61,877,739 | 11,279 |
| DENOSUMAB | $61,551,609 | 243,538 |
| RANIBIZUMAB | $52,616,482 | 45,373 |
| OCRELIZUMAB | $46,758,534 | 2,688 |
| RIVAROXABAN | $42,293,958 | 624,256 |
| GLECAPREVIR + PIBRENTASVIR | $42,211,857 | 2,255 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $25,707,714 | 3,826,634 |
| ATORVASTATIN | $22,309,704 | 3,033,679 |
| PANTOPRAZOLE | $17,995,990 | 2,469,405 |
| ESOMEPRAZOLE | $22,698,248 | 2,153,309 |
| PERINDOPRIL | $11,728,850 | 1,790,739 |
| ESCITALOPRAM | $6,282,850 | 1,463,251 |
| METFORMIN | $11,445,575 | 1,439,769 |
| SERTRALINE | $6,274,410 | 1,365,661 |
| AMLODIPINE | $7,425,106 | 1,189,146 |
| CEFALEXIN | $5,640,129 | 1,124,989 |
| TELMISARTAN | $6,995,805 | 1,112,500 |
| PREGABALIN | $16,822,080 | 1,064,659 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $3,693,537,484 |
| Patients | $816,055,817 |